75F40122F19003↗

American Institutes for Research in the Behavioral Sciences received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $0 obligated so far for special studies/analysis- other. Its period of performance ended 2023-12-15.

Key facts · data as of Oct 26, 2026

Recipient
American Institutes for Research in the Behavioral Sciences
Awarding agency
Food and Drug Administration (Department of Health and Human Services)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Obligated to date
$0
Potential value
$311.1K
Ends
2023-12-15

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.

Cite this page: SpendQuery, Award 75F40122F19003, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75F40122F19003_7524_75F40120A00015_7524

QUALITATIVE DEVELOPMENT TOWARD A PATIENT-REPORTED OUTCOME MEASURE (PROM) OR PERFORMANCE OUTCOME (PERFO) MEASURE FOR OCULAR BIOELECTRONIC IMPLANTS

Bpa Call · Food and Drug Administration · to American Institutes for Research in the Behavioral Sciences (UEI MCN6J5L6M3T4) · data as of 2026-10-26

Obligated to date$02 actions
Current value$311.1Kwith options exercised
Period2022-06-02 → 2023-12-15current end date

What it is

Product or service
Special Studies/Analysis- Other (PSC B599)
Industry
Administrative Management and General Management Consulting Services (NAICS 541611)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Competition
Full and open competition
Pricing
Firm fixed price
How it was bought
Blanket purchase agreement (BPA) · under 75F40120A00015
Where the work is
Montgomery, MD · district MD-08

Obligations by fiscal year

FY2023$0

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2022-10-19. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2022-12-29P00002Administrative change$0QUALITATIVE DEVELOPMENT TOWARD A PATIENT-REPORTED OUTCOME MEASURE (PROM) OR PERFORMANCE OUTCOME (PERFO) MEASURE FOR OCULAR BIOELECTRONIC IMPLANTS
2022-10-19P00001Administrative change$0QUALITATIVE DEVELOPMENT TOWARD A PATIENT-REPORTED OUTCOME MEASURE (PROM) OR PERFORMANCE OUTCOME (PERFO) MEASURE FOR OCULAR BIOELECTRONIC IMPLANTS

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗